Proveris Scientific Corporation
Al Correia is an accomplished professional with extensive experience in leadership roles within the scientific and biomedical sectors. Currently serving as Vice President of Technical Services at Proveris Scientific Corporation since October 2018, Correia has previously held significant positions such as Vice President of Commercial Operations at Horizon Technologies Inc, and Vice President roles at Seqll, Harvard Apparatus Regenerative Technology, and Harvard Biosciences. Correia's earlier career includes notable positions as Vice President of Sales & Operations at Cambridge Biomedical and Vice President of Marketing at VelQuest Corporation, along with various leadership roles at Unisyn Technologies and Zymark Corporation. Al Correia holds a Bachelor of Science degree in Chemistry from the College of the Holy Cross.
This person is not in any teams
Proveris Scientific Corporation
Why Proveris Scientific? Proveris helps pharmaceutical companies developing orally inhaled and nasal drug products (OINDPs) reach the market sooner, saving significant time and money. Proveris believes that developing effective OINDP products requires in-depth knowledge and expertise to understand and control the complex relationships among drug delivery devices, formulations, and human usage that drive product performance. Proveris believes that applying intelligent automation technology, modern data analysis, and proven experimentation techniques leads directly to superior product knowledge and to successful therapies reaching patients far sooner than possible any other way. For more than 20 years, Proveris has worked closely with pharmaceutical companies, device suppliers, contract development, research, and manufacturing organizations, and global regulatory agencies who believe in this focus to elevate the standards in the industry and deliver effective therapies. Proveris does extensive product testing to understand the challenges of developing OINDP products and successfully bringing them to market. By working in its own laboratory and with a broad range of industry influencers, Proveris has unique knowledge and experience in synthesizing the complexities of OINDPs to deliver value-oriented solutions to its customers. Through its patented Proveris by Design™ process, Proveris identifies the human usage performance of an OINDP according to current FDA and ICH guidelines for in vitro testing. Proveris assists with pump, valve, and device selection to optimize effective drug delivery, develops testing strategies, conducts method development studies, and delivers and maintains instruments needed for research and on-going quality assurance testing. Proveris is certified to ISO 9001:2015.